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Highlights
 The epidemiology between community-, healthcare- and livestock-associated 
MRSA is blurring.
 Genomic studies have helped understand the genetic changes associated 
with the evolving epidemiology.
 Genomics-based diagnostic tools such as whole-genome sequencing are 
useful in providing rapid information in relation to epidemiology and outbreaks.
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ABSTRACT
The evolution of meticillin-resistant Staphylococcus aureus (MRSA) from meticillin-
susceptible S. aureus has been a result of the accumulation of genetic elements 
under selection pressure from antibiotics. The traditional classification of MRSA into 
healthcare-associated MRSA (HA-MRSA) and community-associated MRSA (CA-
MRSA) is no longer relevant as there is significant overlap of identical clones 
between these groups, with an increasing recognition of human infection caused by 
livestock-associated MRSA (LA-MRSA). Genomic studies have enabled us to model 
the epidemiology of MRSA along these lines. In this review, we discuss the clinical 
relevance of genomic studies, particularly whole-genome sequencing, in the 
investigation of outbreaks. We also discuss the blurring of each of the three 
epidemiological groups (HA-MRSA, CA-MRSA and LA-MRSA), demonstrating the 
limited relevance of this classification.
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1. Introduction
Staphylococcus aureus is associated with a variety of diseases in humans, including 
superficial infections, deep-seated infections, acute sepsis, respiratory infection and 
toxin-mediated illnesses. The first clone of meticillin-resistant S. aureus (MRSA) was 
identified in 1961. Molecular epidemiological evidence suggests MRSA has evolved 
on multiple occasions from lineages of meticillin-susceptible S. aureus (MSSA) 
isolates. Although MRSA was initially a healthcare-associated pathogen dominated 
by distinct lineages and often associated with multidrug resistance, the emergence of 
genetically distinct community-associated MRSA (CA-MRSA) infections in the last 
two decades has led to a significant clinical impact outside the hospital setting. 
Moreover, CA-MRSA has also become established in healthcare settings and it has 
been suggested that these clones will replace the healthcare-associated MRSA (HA-
MRSA) clones over time. In addition, CA-MRSA is slowly acquiring resistance to 
other antibiotics and as a result phenotypic distinctions between HA-MRSA and CA-
MRSA are blurring [1]. Livestock-associated MRSA (LA-MRSA) is genetically distinct 
from CA-MRSA and HA-MRSA and has its main reservoir in farm animals [2]. 
Recent reports also suggest a blurring of this epidemiology and possible 
transmission of LA-MRSA between humans.
Genomic studies, particularly using whole-genome sequencing (WGS), enhance our 
understanding of the key features of each MRSA type and the genetic changes 
associated with changing epidemiology. They also allow us to map global, national 
and regional spread of variants and to investigate the selective pressures that shape 
the population. The introduction of WGS technology into routine diagnostics in 
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healthcare provides promise of rapid access to resistance, virulence, host adaptation 
and outbreak information, thus improving patient management, infection control and 
biosecurity.
This review is a summary of the discussions that took place at the 5th MRSA 
Working Group Consensus Meeting of the International Society of Chemotherapy in 
Verona, Italy, in May 2014.
2. The emergence of MRSA
MRSA emerged from MSSA lineages with acquisition of the staphylococcal cassette 
chromosome (SCC) element that carries either mecA or mecC (SCCmec). SCC 
elements are large segments of DNA that carry variable arrays of genes, which can 
include genes that encode resistance to antibiotics other than meticillin. Diverse 
SCCmec types (SCCmec types I–XI) have been described [3]. Acquisition of other 
mobile genetic elements (MGEs) carrying virulence genes and other antibiotic 
resistance determinants may lead to further adaptation of MRSA lineages [4]. MGE-
encoded virulence factors such as enterotoxins, Panton–Valentine leukocidin (PVL), 
other bicomponent leukocidins, toxic shock syndrome toxin and staphylokinase are 
carried by bacteriophages or S. aureus pathogenicity islands (SaPI) [5]. A wide 
range of antimicrobial resistance genes can also be carried on plasmids and 
transposons [6]. These genes can confer resistance to penicillins, macrolides, 
aminoglycosides, tetracyclines, chloramphenicol, fusidic acid, mupirocin, linezolid 
and biocides.
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Molecular typing techniques such as multilocus sequence typing (MLST) have 
defined the S. aureus population structure [7]. MLST assigns isolates to a sequence 
type (ST) based on the allelic profile of the sequence within seven housekeeping 
loci. Isolates that share five of the seven alleles may be grouped together into clonal 
complexes (CCs) that describe lineages. MRSA commonly associated with human 
infections worldwide is due to a limited number of lineages including CC1, CC5, CC8 
(and related ST239), CC22, CC30, CC45, CC59 and CC80 [4]. Lineages are 
genetically very distinct from each other with substantial variation in genes encoding 
for surface proteins and regulators, although they originally shared a common 
ancestor prior to SCCmec acquisition [8].
The epidemiology of MRSA in the four decades following identification of the first 
MRSA was principally associated with spread in hospitals. A handful of dominant 
clones accounted for the majority of HA-MRSA worldwide, e.g. ST22 and ST36 in 
the UK, ST239 in Asia and Australia, and ST5 in North America, Japan and Korea. 
These clones were able to establish themselves by their competitive advantage in 
the presence of intensive antibiotic use, most notably but not restricted to -lactams. 
In the late 1980s, MRSA b gan to emerge in the community. CA-MRSA has evolved 
independently of the HA-MRSA clones. In the beginning this was mostly confined to 
closed communities, e.g. Australian aborigines, but around the late 1990s CA-MRSA 
emerged worldwide in the general population. CA-MRSA clones typically possess 
SCCmec type IV or V elements and are often positive for the PVL toxin. Like HA-
MRSA, the distribution of the predominant clones tends to be geographically distinct: 
ST80 in Europe and Northern Africa, ST59 in the Far East, ST93 and ST1 in 
Australia, and ST1 and ST8 in the USA. Since 2005, MRSA from animals (LA-
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MRSA) has increasingly been recognised as a cause of human infections. LA-MRSA 
is predominantly due to the ST398 clone in Europe, whereas ST9/t899 dominates in 
Asia. ST398 and ST9 are tetracycline-resistant and are strongly associated with pig 
farms, although they are also found in a range of other farm animals. Like HA-MRSA 
and CA-MRSA, evolution of meticillin resistance appears to have occurred 
independently; phylogenomic analysis of representatives of the LA-MRSA CC398 
population suggests that this lineage has descended from a human MSSA ST398 
clone, which after a host jump acquired tetracycline and meticillin resistance. In this 
process the LA-MRSA lineage lost the Sa3 phage carrying the human evasion 
genes sak, scn and chp [9]. LA-MRSA marks a paradigm shift in the epidemiology as 
humans hitherto have been the dominant reservoir. Tackling of LA-MRSA requires a 
One Health approach with collaboration of veterinarians, farmers, doctors and 
environmentalists.
The epidemiological definitions for CA-MRSA, HA-MRSA and LA-MRSA (Table 1) 
may not be fit for purpose in future. For example, Folden et al. reported the variation 
in estimating the proportion of CA-MRSA infections using epidemiological definitions: 
use of one set of definitions classified 5% of isolates as CA-MRSA, whilst using 
another set led to as many as 49% of infections to be classified as CA-MRSA [10]. In 
order to avoid such misclassification, the US Centers for Disease Control and 
Prevention (CDC) has provided a definition for CA-MRSA (Table 1) [11]. However, at 
the same time as CA-MRSA is becoming common in the community, changes in 
hospital practice such as reduced length of stay, day-only admissions, and hospital-
in-the-home or community hospitals make application of traditional definitions difficult 
as facilities traditionally available in hospitals are increasingly delivered in the 
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community in a more integrated manner. Miller et al. failed to label any MRSA 
bacteraemia (n = 57) presenting at the Oxford Radcliffe Hospital (Oxford, UK) 
between 2003 and 2006 as caused by CA-MRSA [12]. Problems are also 
encountered when using antibiotic susceptibility pattern or traditional genetic 
signatures as an indicator of epidemiological origin. In the UK, ciprofloxacin 
susceptibility is used widely in clinical laboratories as a marker for CA-MRSA, but the 
resistance pattern is variable in America where levels of ciprofloxacin resistance 
approach 80% in some high-risk groups [13]. Similarly, PVL detection should not be 
used as a sole marker for CA-MRSA [14]. Genetic definitions that use the SCCmec
type IV element as a marker for CA-MRSA are flawed as they potentially include the 
EMRSA-15 (ST22) and USA800 (ST5) clones, which are epidemiologically HA-
MRSA. As the distinction between HA-MRSA and CA-MRSA becomes increasingly 
blurred, a classification based solely on the SCCmec type IV element is no longer 
helpful. Identification of markers associated with different epidemiological niches 
becomes valuable when combined with stable genetic markers identifying the origin 
of a successful clone such as clonal complex and SCCmec type.
Each MRSA clone has emerged as a result of genetic variation such as acquisition 
of resistance, virulence and host adaptation genes, coupled with selective pressures 
such as antimicrobial usage that allow it to expand in healthcare, community and 
animal husbandry niches. As the number and quantity of antibiotics being used 
increases, so does the selective pressure exerted on the S. aureus population to 
develop and maintain resistance. Such conditions favour horizontal transfer of novel 
mobile resistance elements, and consequently have the potential to drive the 
emergence of a new ‘super bug’ with a fully multidrug resistance spectrum. For 
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example, gene transfer from vancomycin-resistant enterococci led to the emergence 
of vancomycin-resistant S. aureus (VRSA) [15]. Fortunately, the relative fitness of 
these isolates is thought to be compromised [16]. Also alarming is the emergence of 
linezolid-resistant S. aureus (LRSA) belonging to the USA300 clone possessing the 
cfr resistance gene. Three such isolates were identified as part of routine 
surveillance in the New York region of the USA [17]. An outbreak of LRSA has also 
been reported in Spain [18].
In the remainder of the paper, we will further discuss the three epidemiological types
of MRSA with particular reference to the contribution of genomic information to our 
understanding of their emergence, spread and global dissemination, virulence and 
antibiotic resistance.
3. Hospital-associated meticillin-resistant Staphylococcus aureus
(HA-MRSA)
One of the most globally prolific clones of HA-MRSA in recent years is the epidemic 
MRSA 15 (EMRSA-15) clone, which belongs to the ST22/CC22 lineage. EMRSA-15 
was first described in 1991 in England, from which point it spread rapidly all over the 
UK, such that 15 years later two-thirds of all MRSA bacteraemia episodes were 
caused by this clone. Phylogenomic studies have proposed that pandemic MRSA 
CC22 emerged in the mid 1980s in the UK Midlands and coincided with the 
introduction of fluoroquinolone antibiotics in the UK. The acquisition of 
fluoroquinolone resistance by the EMRSA-15 clone through mutation was a seminal 
event in its emergence. This resistance pre-dated the clinical licensing of 
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fluoroquinolones, but occurred at a time when fluoroquinolones were used in clinical 
studies in the UK. In support of the importance of fluoroquinolone resistance in 
selecting for HA-MRSA, a decline in prescribing of fluoroquinolones in the UK has 
been followed by the decline of MRSA in hospitals [19,20].
Fluoroquinolone resistance is almost universal in EMRSA-15 isolates [21]. However, 
this lineage is also capable of carrying a variety of different genes located on MGEs 
that confer resistance to aminoglycosides, macrolides, chloramphenicol, 
trimethoprim/sulfamethoxazole, fusidic acid, mupirocin, tetracycline and antiseptics, 
highlighting the selection pressure placed on EMRSA-15 [20]. Evidence of how 
regional prescribing regimens generate regional adaptation can be found in the 
genetic determinants associated with clindamycin resistance. Holden et al. examined 
EMRSA-15 from Germany, where clindamycin use is high, and found that the 
majority of isolates contained multiple independent mutations to the ermC leader 
peptide region rendering them resistant to clindamycin as well as erythromycin. In 
contrast, in the UK where the use of clindamycin is limited, all EMRSA-15 ermC
leader peptides were intact, therefore making these isolates susceptible to 
clindamycin [21]. The human EMRSA-15 epidemic has also spread into the 
companion animal population [22,23], with veterinary hospitals also being healthcare 
settings that may experience high levels of transmission [24].
A noticeable feature of EMRSA-15 is its propensity to spread, expand and replace 
the dominant HA-MRSA. EMRSA-15 overtook the previously successful CC30 HA-
MRSA epidemic MRSA 16 (EMRSA-16; ST36-II) clone in the UK in the early 2000s. 
The replacement of resident HA-MRSA clones by EMRSA-15 has been well 
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documented in Portugal, Singapore and Australia [25–27]. One feature that may 
contribute to its success is the SCCmec IV element that this clone carries, which has 
a lower fitness cost than the larger SCCmec elements such as SCCmec types II and 
III that were prevalent in earlier HA-MRSA clones [28]. In addition, some variants of 
CC22 HA-MRSA have acquired the PVL-associated genes, causing outbreaks 
among neonates in Australia [29] and the UK [30].
Another interesting pandemic HA-MRSA clone is ST239-MRSA-III, widespread in 
Australian, Asian and South American hospitals. Epidemiological studies using WGS 
of global populations clearly showed that isolates were clustered into regional groups 
indicating localised evolution, but that transmission to other continents occurred 
sporadically [31]. There were clear associations between isolates from countries with 
close cultural links, such as Portugal and Brazil. There was also evidence of direct 
introduction of Asian isolates to Australia [32], the UK and Denmark. However, these 
MRSA failed to become established in hospitals in the UK and Denmark [20].
Other widespread HA-MRSA clones include CC5 [predominately ST5-MRSA-II (New 
York/Japan MRSA/USA100) and ST5-MRSA-VI (Paediatric clone)], CC8 [ST247-
MRSA-I (EMRSA-17/Iberian MRSA)], CC30 [ST36-MRSA-II (EMRSA-16/USA200)] 
and CC45 [ST45-MRSA-IV (Berlin MRSA/USA600)] [33]. The ST5 MRSA clone has 
been predominant in hospitals in America [34]. Data from the Active Bacterial Core 
Surveillance (ABCs) from the CDC indicate that USA100 (ST5) is the predominant 
strain type, although from 2004 onwards the more virulent type USA300 (ST8) 
isolates are increasingly recognised as a cause of hospital-associated bacteraemia 
[35–37]. Indeed, the USA300 epidemic peaked in 2004 leading to the mathematical 
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predictions that the USA300 CA-MRSA strains will eventually displace the HA-MRSA 
strains owing to the survival advantage of the former as a result of smaller and fewer 
genes leading to enhanced fitness [38]. Whilst USA300 continues to be a 
predominant clone, there are significant regional differences in the proportion of 
bloodstream infections caused by USA300 clone. Jenkins et al. found that the 
proportion of USA300 clone ranged from 19% to 62% of the bloodstream MRSA 
isolates even within Denver, CO [39]. The incidence of USA300 in invasive infections
has declined since the peak in 2004 [40]. Thus, whilst different countries and regions 
have different dominant clones, they also have different rates of MRSA infection, 
different prescribing practices and healthcare systems, each providing unique 
selective pressures that have a profound effect on strain dynamics.
4. Community-associated meticillin-resistant Staphylococcus 
aureus (CA-MRSA)
CA-MRSA has been circulating in Europe since the 1990s [41–43]. In the beginning, 
the CC80 lineage predominated the epidemiological group. The CC80 clones 
possess the PVL-associated genes that encode the PVL toxin. Phylogeographical 
analysis reveals that CC80 emerged in sub-Saharan Africa in the 1980s before 
rapidly disseminating into Europe, most likely via coastal areas of Guinea, as a result 
of human migration. This imported lineage then spread throughout Europe within 10 
years, followed by another secondary spread a few years later. At the time it was 
introduced into Europe the CC80 lineage contained the PVL-associated genes. 
Genes encoding PVL were subsequently acquired as it spread across continents. In 
terms of resistance to antibiotics, the African ancestor lineage was generally 
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susceptible except for tetracycline, whilst fusidic acid resistance was acquired 
following introduction into Europe where topical use of fusidic acid is widespread in 
some regions [44].
The American story of CA-MRSA is strikingly different. In the USA, CA-MRSA was 
first documented in children during the late 1990s. The isolates belonged to a single 
clone, designated USA400 (belonging to CC1), and caused sepsis with pneumonia 
associated with high lethality. The USA400 clone has subsequently been replaced 
by USA300, a member of CC8, which is now the most common CA-MRSA in 
America. Accompanying this shift in the MRSA population was a change in the 
epidemiology of CA-MRSA disease; CA-MRSA is typically associated with skin and 
soft-tissue infection. Amongst the MGEs that USA300 isolates carry is a type I 
arginine catabolic mobile element (ACME) containing the speG gene. The product of 
this gene, spermidine N-acetyl transferase, degrades host polyamines (e.g. 
spermidine) that are lytic to the bacteria, thus enhancing the fitness of the bacteria to 
survive within the host [45]. Within the CC8 lineage, nine clades have been 
identified, designated clades CC8-A to CC8-I [46]. This lineage has undergone a 
multiclonal expansion, in contrast to the European CA-MRSA CC80 that has given 
rise to a single successful clone with a clear geographical pattern of emergence and 
spread. Some clades within the CC8 (clades CC8-A, CC8-C, CC8-D and CC8-E) 
population appear to be geographically diverse, whereas others are geographically 
restricted to a single area (e.g. clade CC8-B in Europe). The multiclonal expansion is 
reflected in the diverse antibiotic resistance pattern of the CC8 lineage. Some clones 
are fully susceptible whilst others are multiresistant, particularly those belonging to 
CC8-E. Phylogenetic analysis reveals a stepwise incremental gain in antibiotic 
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resistance genes. The older representatives of CC8-E population harbour resistance 
to as many as nine antibiotics, whilst the newer clades such as clade CC8-A are 
pauci-resistant (resistance often limited to two antibiotics).
This appears to support the hypothesis that USA300 may be on the same trajectory 
as CC8-E was at one point in its evolutionary history and could in the future become 
multiresistant. Clade CC8-A also carries the PVL-associated genes and contains 
isolates that belong to the USA300 clone. In a study investigating the genomics of 
USA300, Uhlemann et al. found evidence for at least five different acquisitions of the 
lukSF-carrying prophage into the ST8 population, but only a single event into 
USA300 clone [47]. From their phylogenomic analysis, the authors concluded that 
acquisition of the lukSF-carrying prophage coincided with the acquisition of ACME 
and occurred between 1970 and 1993, resulting in the emergence of USA300. The 
USA300 clone has spread to other continents including Europe and South America 
[48]. The expansion of USA300 in Europe may have occurred as a single point 
introduction followed by spread, or by multiple introductions over a long period of 
time followed by limited spread on each occasion. WGS data on the French isolates 
reveal that following multiple introductions, the lineage has stabilised and may even 
decline [49].
Another clinically relevant gene associated with USA300 clone is the msrA gene 
encoding resistance to macrolides and streptogramins. This gene is carried on the 
rep16 plasmid, and at least eight rep family plasmids have been identified within the 
CC8 lineage. The rep16 plasmid was acquired more recently when it replaced the 
rep20 plasmid typical of the older isolates within clade A [46]. A feature of CA-MRSA 
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in the USA is high levels of genetic variation. Carpaij et al. found great diversity 
related to the acquisition of genes among 13 subtype USA300-0114 isolates isolated 
over a short period of 1 month from one single location, suggesting ongoing 
evolution of the clone [50].
In keeping with their geographical isolation, the epidemiology of CA-MRSA in 
Australia and New Zealand is unique. One of the earliest reports of CA-MRSA from 
this region was when infections caused by ST8 MRSA clone were reported amongst 
indigenous communities in Western Australia [51]. Later, ST30 CA-MRSA infections 
were reported from New Zealand, and more recently non-pigmented CC75 from 
Northern Australia. CC75 is sufficiently different from the other S. aureus lineages to 
the extent that a new species name has been proposed: Staphylococcus argenteus 
[52,53]. The other CA-MRSA lineages identified in the Australian survey include 
ST93-MRSA-IV, ST30-MRSA-IV, ST1-MRSA-IV, ST45-MRSA-IV, ST78-MRSA-IV 
and ST5-MRSA-IV (denoted by sequence type followed by SCCmec carriage). The 
CA-MRSA type that now predominates in New Zealand is the fusidic acid-resistant 
ST5-MRSA-IV clone [54].
The full epidemiological picture in Asia and Africa is unclear as data are lacking from 
many regions and from prior to the turn of the century. The dominant Asian clones 
include ST59-MRSA-IV/V in China, Taiwan, Singapore and Hong Kong, ST72-
MRSA-IV in Korea, ST30-MRSA-IV in Japan and the Western Pacific, ST80-MRSA-
IV in the Middle East, and the PVL-positive Bengal Bay clone ST772-MRSA-V in 
India. The latter clone has since been reported from various countries in Europe, the 
Middle East and Australasia. Closely related to the CC1 lineage, the ST772 has 
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several distinguishing features such as resistance to multiple antibiotics, different 
accessory gene regulator (agr) group (group II), and capsule type 5 rather than 8 
[55]. The African origin of the European CA-MRSA clone has been well described, 
and CA-MRSA has been reported from Egypt, Mali, Algeria and Nigeria. Sampling of 
individuals from the remote Babongo tribes in Gabon found a high percentage (55%) 
of PVL-positive clones of MSSA, but MRSA was not detected in any of the samples. 
The MSSA clones found in this study include the common clonal lineages CC1, CC5, 
CC30 and CC80, despite the remote location of this tribal population [56].
5. Livestock-associated meticillin-resistant Staphylococcus aureus
(LA-MRSA)
Infections with LA-MRSA can occur in people who have direct contact with farm 
animals in factory farms (especially pig and poultry production systems). This affects, 
for example, farmers, veterinarians or slaughterhouse employees. MRSA was first 
described in animals in 1972 when it was found in a cow [57]. However, it was not 
until 2005 when CC398 MRSA was reported from pigs both in France and The 
Netherlands that livestock was shown to be an important zoonotic reservoir for 
MRSA. Pigs are the main reservoir for CC398, but this clone has also been found in 
veal calves (especially in The Netherlands and Belgium), poultry, horses and, to a 
lesser extent, dairy cows. In addition, CC398 has been found in pets such as dogs 
and cats as well as in rodents. There is a general consensus that the prevalence of 
CC398 is increasing rapidly worldwide. However, precise information on the true 
prevalence of CC398 in animals is difficult to obtain. In The Netherlands it is 
estimated that >80% of all farms are MRSA-positive. In Denmark, a recent 
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surveillance study showed that 60–70% of all pig herds are positive, whereas in 
Norway only a very few farms have been found to be positive. However, in most 
other countries no systematic surveillance on CC398 or other types of LA-MRSA is 
performed in animals (the same holds true for the surveillance of these strains in 
humans).
Whilst CC398 MRSA is the overwhelmingly dominant lineage in livestock in Europe, 
CC9 MRSA is the predominant type in Southeast Asia. In addition to these two 
clonal complexes, a number of other MRSA lineages including CC1, CC5, CC97, 
CC121, CC130 and ST425 have been reported from livestock [58]. MRSA belonging 
to CC130 and ST425 are meticillin-resistant due to the recently described mecC 
gene instead of the mecA gene. The mecC gene only has ca. 70% similarity to the 
mecA gene [59]. As a result, molecular diagnostic assays need to encompass 
primers for both types. CC97, a widely disseminated human CA-MRSA type, is also 
interesting as it descended from bovine MSSA and has acquired SCCmec after the 
bovine-to-human host adaptation. This is in contrast to the livestock clade of CC398 
that acquired SCCmec after jumping from humans to pigs [9,60].
The risk factors for transmission between herds are not fully elucidated. Trade of 
MRSA-positive pigs is the most important risk factor. However, several herds have 
been found positive without acquisition of new animals for many years prior to the 
detection of MRSA CC398. In these cases, introduction from MRSA-positive humans 
(such as veterinarians or new employees) or from rodents are possible transmission 
routes. Within herds, use of antimicrobials, particularly -lactams and tetracyclines, 
and trace metals including zinc are important selective pressures [61]. The latter is 
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substantiated in the dominant SCCmec V (5C2&5) cassette, which includes the czrC 
gene [62].
By far the most important risk factor for LA-MRSA in humans is repeated direct 
occupational contact with animals positive for MRSA. The extent of the risk is 
dependent both on contact time and contact intensity. In Denmark, 70% of all new 
cases found in 2013 reported direct contact with pigs and an additional 17% were 
household members of persons with close contact with live pigs. Of the remaining 
13% with no pig contact, the majority of cases lived in rural areas with high pig 
density, whereas few occurred in urban areas. This indicates that transmission 
occurs via local spillover from persons working at livestock farms or through contact 
with the farm environment itself rather than through a generalised spread in the 
community [63]. The relative contribution of transmission via the environment or via 
humans in contact with pigs is unknown. However, based on knowledge of 
transmission of S. aureus in other settings, transmission through human-to-human 
contact is likely to predominate [64].
As MRSA has been found on meat in 10–20% of samples tested on many 
occasions, there have been reports in the lay press on the risk of acquisition of 
MRSA via the food chain. The epidemiology on LA-MRSA, however, clearly shows 
that meat is not an important route of transmission. If it were the case, one would 
see a very different geospatial distribution among cases not associated with pig 
contact [63]. Further evidence against this route of transmission is provided by the 
low incidence of LA-MRSA found in slaughterhouse workers. There may be some 
risk of acquisition of MRSA as a result of handling of meat, rather than ingestion, but 
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this risk is not significant and clearly has not been associated with widespread 
transmission. Washing hands immediately after handling food is a very effective way 
to block transmission.
The increasing reservoir of LA- MRSA in pigs as well as in humans in direct contact 
with pigs results in an increasing number of cases in the general community, 
particularly in immunocompromised individuals. Therefore, unless this epidemic is 
contained, it is likely that we will see increasing numbers of severe infections due to 
LA-MRSA. Köck et al. reported that 16 (8%) of 194 MRSA bacteraemia episodes in 
Germany diagnosed during the years 2008–2012 were due to MRSA CC398 [65]. 
Furthermore, the greater the human carriage of LA-MRSA clones, the greater the 
risk that these clones will undergo adaptation enhancing human-to-human 
transmissibility.
Measures to counteract the expanding reservoir in pigs are thus urgently needed, as 
are measures to lower the bacterial burden in the farm environment.
6. Application of genomics in epidemiological settings and 
outbreak investigations
Modern genetic tools have greatly expanded our knowledge of the epidemiology of 
MRSA infection and allowed a closer examination of outbreaks in the hospital and 
the community. Classical typing methods or antibiogram may not have sufficient 
resolution power to link MRSA clones during an outbreak investigation. For example, 
WGS has been used retrospectively in an outbreak in a Special Care Baby Unit in a 
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UK hospital in Cambridge [66]. Of the 17 cases in the unit over a 6-month period, 12 
appeared to be linked based on identical or near-identical antibiotic susceptibility 
patterns. However, WGS data revealed that 14 of the 17 isolates belonged to a new 
type, ST2371 (a single-locus variant of ST22 that possesses the PVL-associated 
genes). Thus, only three of the five isolates excluded as a result of antibiogram 
mismatch were correctly excluded: the remaining two were in fact associated with 
the outbreak. Also, the sequencing data identified additional cases, both 
retrospectively and prospectively, linked to the outbreak but beyond the parameters 
of the outbreak as defined in the traditional infection control investigations. Following 
a new case more than 2 months after the outbreak was thought to have ceased, 
screening of staff identified a single MRSA carrier. WGS of colonies of S. aureus
from this individual identified genetic overlap in the colonising population of the staff 
member and the outbreak population. The application of WGS for the near real-time 
analysis of outbreaks has great utility. Moreover, the technique encompasses the 
information provided by the more traditional genotyping tools such as sequence 
typing coupled with the detection of specific genes such as those encoding PVL toxin 
and other virulence determinants. The rapid detection of genes associated with 
pathogenicity, transmission and resistance may help in limiting spread within 
hospitals by timely adherence to strict infection control protocols, and may also help 
in characterising atypical clones that pose a threat. These clones may be 
misreported in routine clinical laboratories. Recent sequencing work on four clones 
from Scotland identified several single nucleotide substitutions in the transpeptidase 
domains of penicillin-binding proteins (PBPs) 1, 2 and 3 that can explain resistance 
to -lactamase-stable penicillins [67]. Transmission of MRSA in the setting of 
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deceased donor liver transplant was confirmed using WGS in a recent report [68]. 
The diagnostic value of WGS cannot be overemphasised.
WGS has also been used for understanding the epidemiology and transmission 
dynamics of MRSA by creating a sequencing database. Based on the numbers of 
single nucleotide polymorphisms (SNPs) and their dispersion within the genome, it is 
possible to discriminate between the timing of acquisition and the relationship 
between isolates. Bartels et al. found 59 SNP differences between two isolates 
belonging to the ST80 clone from the same household, which indicates long-term 
carriage based on the fact that SNPs are acquired at a predictable rate [69]. 
Application of WGS in human infections with MRSA carrying the mecC gene 
identified two distinct clusters with transmission confined between individuals and 
their livestock, with only small differences in SNPs between the animal and the 
human isolates, supporting zoonotic transmission. MLST, pulsed-field gel 
electrophoresis (PFGE) and multilocus variable-number tandem repeat analysis 
(MLVA) were unable to distinguish between the two clusters [70].
7. Conclusion
The story of MRSA is one of dramatic recent success driven by the widespread use 
of antibiotics. Staphylococcus aureus clones have co-evolved with humans, and 
MRSA have emerged from the population on multiple occasions. The rapid spread of 
MRSA has been aided by human migration, which itself has reached a level never 
seen before in the history of mankind. MRSA has adapted to the environments and 
conditions that humans have created and where they have thrived. Clones have 
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jumped from one host species to another, have amplified in the niche areas, and 
then gone back to colonise the population where it emerged while still retaining a 
strong foothold in specialised environments. There is significant overlap between 
clones across the traditional groups (HA-MRSA and CA-MRSA) as well as some 
blurring of the groups themselves as healthcare is increasingly delivered in the 
community. Newer technologies such as WGS will lead to a better epidemiological 
understanding of MRSA. Use of antibiotics in humans and livestock has given this 
highly adaptive species a survival advantage, as it is easily able to acquire 
resistance. Staphylococcus aureus has not lost its virulence either, as it continues to 
be a primary human pathogen with significant mortality associated with invasive 
disease.
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Table 1
Definitions of community-associated (CA), hospital-associated (HA) and livestock-
associated (LA) meticillin-resistant Staphylococcus aureus (MRSA)
MRSA Definition and/or salient features
HA-
MRS
A
Identified >48 h after admission to a healthcare facility, or MRSA identified 
in an individual with history of MRSA infection or colonisation, admission 
to a healthcare facility, dialysis, surgery or insertion of indwelling devices 
in the past year
CA-
MRS
A
Identified in the outpatient setting or within 48 h following hospital 
admission in an individual with no medical history of MRSA infection or 
colonisation, admission to a healthcare facility, dialysis, surgery or 
insertion of indwelling devices in the past year
LA-
MRS
A
No formal definition. Usually belong to CC398 lineage in Europe but often 
CC9 in Asia. Acquired via occupational contact with livestock
CC, clonal complex.
